Vertex Signs LOI With pCPA For ALYFTREK In Cystic Fibrosis Treatment

Vertex Pharmaceuticals Inc NASDAQ:VRTX:

• VERTEX SIGNS LETTER OF INTENT (LOI) WITH THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE FOR ALYFTREK FOR THE TREATMENT OF CYSTIC FIBROSIS

• VERTEX PHARMACEUTICALS - TO INITIATE DISCUSSIONS FOR PUBLIC LISTING OF ALYFTREK IN CANADA